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Background
Pro12Ala polymorphism in PPAR-g2 gene is known to be involved in insulin sensitization and metabolic deregulation in Type 2 Diabetes (T2D) subject. Considering beneficial effects of Vitamin D 3 in functional regulation of pancreatic-β cells, present population based study was designed to determine the association of Pro12Ala polymorphism with serum Vitamin D 3 level and its effects on glucose homeostasis in T2D and non-diabetic subjects.
Materials & methods
Total 508 subjects (including 210 T2D & 298 controls) were divided into two groups according to serum Vitamin D 3 level. GrouPI: included 338 subjects (150 T2D out of 338) having Vitamin D 3 deficiency (≤25.0 nmol/l) and group-II: included 170 subjects (60 T2D out of 170) with normal vitamin D 3 level (>25.0 nmol/l). All cases were investigated for Vitamin D 3 , glycosylated hemoglobin (HbA1C) level and Pro12Ala variant of PPAR-g2 gene.
Results
It was observed there is 12Ala allele frequency of PPARγ2 gene in 10.19% of T2D and 9.46% in control subjects (p>0.36). The mean HbA1C was better controlled in group-II T2D subjects with 12Ala allele compared to group-I T2D subjects having same allele (7.26±0.44% vs. 8.35±0.43%, p>0.014). In contrary to the above, patients who were homozygous for 12Pro allele, the mean HbA1c remains high irrespective of the normal Vitamin D 3 levels (8.59±0.18% vs. 8.29±0.28% in group-I and group-II respectively). 
Conclusions

